Vernalis Plc | Reg No. 02304992 | SIC Code 7415 | HQ South East | Tel 0118 9773133 | Turnover £14.2m | Employees 90 | Locations 2 | 16 Company Alerts
VER - LSE: VER Vernalis Results of Annual General Meeting Resolutions Vernalis plc (LSE: VER) announces that all resolutions proposed to shareholders at its Annual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votes re...
22 May 2012
Executive Management Team expanded - New Head of Business Development appointed - view original
York based ACM Global Central Lab, which specialises in central laboratory testing for clinical trials, has expanded its Executive Management Team and appointed Isabel Struik as Head of Business Development in Europe. Ms Struik will be responsible for business development efforts throughout the region.
21 May 2012
Revenue up 18% to 23bn - international expansion strategy - view original
Alliance Boots Holdings Limited | Reg No. 04452715 | SIC Code 7415 | HQ London | Tel 020 7495 8880 | Turnover £11,502.0m | Employees 53789 | Locations 1500 | 59 Company Alerts | 81 Subsidiary Alerts
Alliance Boots recorded an 18% increase in revenue to 23bn in the year to March 2012. Trading profit increased 12.4% to 1.2bn. The strong performance was achieved through organic growth and acquisitions. The group expects profitable growth and international expansion to continue despite the difficult economic environment.
21 May 2012
£160,000 investment - new marketing strategy - creating 15 jobs - view original
Job Gains / Losses: 15 Jobs Gained Marketing: 15 Jobs Gained Business Performance: 15 Jobs Gained Northern Ireland: 15 Jobs Gained Property, Land & Constr.: 15 Jobs Gained
Environmental health company Healthy Buildings (Ireland) is investing over £160,000 in an expansion which will create 15 jobs. The Belfast-based firm has received £30,000 from Invest NI to create a marketing strategy for Scotland and the north of England. It employs 60 people and hopes to increase sales in Great Britain to £500,000 by 2013.
18 May 2012
Business expansion - New CEO, COO and VP appointed - Current CEO steps down
17 May 2012
Cellzone fully acquired - Company growth -
16 May 2012
70 Jobs Lost - Manufacturing Transfering to China
16 May 2012
450 Jobs Lost - Factory Closure
16 May 2012
New e-commerce website - new brand identity
16 May 2012
£18m investment - workforce to treble - acquired by BASF - new manufacturing facility
15 May 2012
400 jobs at risk - winding down Swindon operation
15 May 2012
Sales up 4% to 432.6m euros - positive business outlook
14 May 2012
New finance director - From June 2012
14 May 2012
£30m acquisition fund - withdraws from drug development
14 May 2012
Acquires manufacturing plant - expansion into collagen products - potential new jobs
14 May 2012
Bid for Human Genome Sciences increased - US expansion
11 May 2012
Secures Business of the Year award - recognised for manufacturing excellence
10 May 2012
Launching recruitment campaign - commercialising diagnostic product - business expansion
09 May 2012
Substantial turnover growth expected - £290,000 funding secured - 19 jobs created
09 May 2012
Lipitor sales fall 42% - decline in revenues and profits - baby food business disposal
The chemicals, pharmaceuticals, biosciences and medical supplies sector is one of the most dynamic areas of the UK manufacturing economy and builds on Britain's traditional strengths in breakthrough scientific advance and technology innovation. It has world leadership in many fields and, in the contexts of globalisation and the gathering industrial strength and low costs base of major developing countries, continues to provide the UK with a competitive edge in high value-added knowledge based products.
22 May 2012
18 May 2012
|
| Developed by Seagrass Software